Approval of the center: study of a medicine for biological therapy of severe plaque psoriasis

Permission has been obtained from the Ministry of Health to conduct a new clinical trial of a drug for the treatment of severe plaque psoriasis at the center. We are preparing for the opening!

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen